In contrast, imipramine treatment reduced insulin resistance, triglycerides, free fatty acids (FFAs), and ALT in mice fed HFD, suggesting that imipramine treatment improves MetS and MetS-related hepatic injury. The gene discussed is GPT; the disease is metabolic syndrome.